Pactiv Evergreen Inc. (NASDAQ:PTVE) Receives $10.60 Consensus Price Target from Analysts
Pactiv Evergreen Inc. (NASDAQ:PTVE – Get Free Report) has been given a consensus rating of “Buy” by the five research firms that are covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have issued a report on the stock in […]
More Stories
Wall Street Weekly: Stocks Fall Amid Policy Uncertainty, Middle East Tensions
By Panos Mourdoukoutas U.S. stocks closed the week lower amid uncertainty over the direction of monetary policy, ongoing tensions in...
Twice as Effective as Metformin: The Power of Lifestyle Changes for Diabetes
By Zena le Roux Twenty-one years after its launch, the U.S. Diabetes Prevention Program remains a landmark study. The latest...
Why Israel Needs US ‘Bunker-Buster’ Bombs to Strike Iran’s Fordo Nuclear Site
By Andrew Thornebrooke President Donald Trump is considering using military force to support Israel’s current campaign to destroy Iran’s nuclear...
QRG Capital Management Inc. Sells 994 Shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
QRG Capital Management Inc. cut its position in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by QRG Capital Management Inc.
QRG Capital Management Inc. decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 1.4% during...
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Cornerstone Wealth Management LLC
Cornerstone Wealth Management LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 21.1% in the...